| Product Code: ETC9949783 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Neurotherapeutics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Neurotherapeutics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Neurotherapeutics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume Share, By Disorders, 2021 & 2031F |
3.7 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Neurotherapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in the United Kingdom |
4.2.2 Technological advancements in neurotherapeutics |
4.2.3 Growing awareness about mental health and neurological disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the UK |
4.3.2 High cost of neurotherapeutics treatments |
4.3.3 Limited healthcare infrastructure in certain regions of the UK |
5 United Kingdom (UK) Neurotherapeutics Market Trends |
6 United Kingdom (UK) Neurotherapeutics Market, By Types |
6.1 United Kingdom (UK) Neurotherapeutics Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Neurological Drugs, 2021- 2031F |
6.1.4 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Neurological Devices, 2021- 2031F |
6.2 United Kingdom (UK) Neurotherapeutics Market, By Disorders |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Peripheral Nervous System Disorders (PNS) Disorder, 2021- 2031F |
6.2.3 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Autonomous Nervous System (ANS) Disorder, 2021- 2031F |
6.2.4 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3 United Kingdom (UK) Neurotherapeutics Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Neurotherapeutic Centers, 2021- 2031F |
6.3.4 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F |
6.3.5 United Kingdom (UK) Neurotherapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Neurotherapeutics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Neurotherapeutics Market Export to Major Countries |
7.2 United Kingdom (UK) Neurotherapeutics Market Imports from Major Countries |
8 United Kingdom (UK) Neurotherapeutics Market Key Performance Indicators |
8.1 Adoption rate of new neurotherapeutics treatments in the UK |
8.2 Patient satisfaction levels with neurotherapeutics therapies |
8.3 Number of clinical trials and research initiatives focused on neurotherapeutics in the UK. |
9 United Kingdom (UK) Neurotherapeutics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Neurotherapeutics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United Kingdom (UK) Neurotherapeutics Market Opportunity Assessment, By Disorders, 2021 & 2031F |
9.3 United Kingdom (UK) Neurotherapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Neurotherapeutics Market - Competitive Landscape |
10.1 United Kingdom (UK) Neurotherapeutics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Neurotherapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here